Professor David Brieger is an interventional cardiologist and head of the coronary care and coronary interventions at Concord Hospital and Professor of Cardiology, University of Sydney. His particular clinical interests include coronary disease and atrial fibrillation and he practices across the full spectrum of cardiac disease. He maintains an active research interest in new antithrombotic drugs for cardiac conditions, and the promotion of high quality care for patients during and following their hospitalization.

Professor Derek Chew is a clinical and interventional cardiologist as well as a clinical trialist and outcomes researcher in cardiovascular medicine. He has completed a Masters of Public Health at the Harvard School of Public Health in quantitative methods.

He is a Senior Principal Research Fellow in Cardiovascular Outcomes Research, and is the Regional Head of Cardiology for the Adelaide Health Service (Southern Region). Derek is the Head of the Flinders Clinical Trial Centre, and Chair of the Statewide Cardiology Clinical Network.

His clinical and research career is centred on the translation of current and future therapies and technologies in cardiology to improved patient outcomes in a clinically effective manner.

Dr Edward Mullins is a Senior Clinical Lecturer at Imperial College, London and the George Institute for Global Health and Honorary Consultant in Obstetrics and Gynaecology at Queen Charlotte’s and Chelsea Hospital, London. He is also an NIHR ARC NWL Improvement Leader Fellow in the 2023 cohort.

His PhD at Imperial College investigated the fetal and maternal inflammatory response in Fetal Growth Restriction. Following this, Ed won a fellowship with Professor Dame Sally Davies, England CMO, as editor-in-chief of the CMO’s annual report, ‘Women: the health of the 51%.’ As an NIHR Academic Clinical Lecturer, Ed has investigated self-monitoring of maternal cardiovascular health and prevention of Gestational Diabetes.

During the COVID-19 pandemic, Ed was seconded as clinical adviser to Professor Chris Whitty, England CMO, and produced rapid reviews on coronavirus infection in pregnancy and in children, which he presented to SAGE and formed the basis of clinical guidelines for the UK.

He is co-CI for PAN-COVID, an NIHR-funded global registry of women affected by suspected COVID-19 or confirmed SARS-CoV-2 infection in pregnancy and their neonates. Ed is also co-CI for COM-SARS-2 study, an historical seroprevalence study in 11,000 maternal serum samples to evaluate the introduction and onset of community transmission of SARs-CoV-2 in NW London.

Ed has led a new clinical service to introduce post-birth contraception for all women in NW London, to allow women to access reliable family planning before discharge from their maternity service. He hopes to evaluate this and support national roll-out.

Srilatha is a trained Public Health professional with specialization in Social Epidemiology from Tata Institute of Social Sciences (TISS), Mumbai. She has experience working at various levels of health system programs for more than 6 years.

At George, she is working with the Mental Health team for project Adolescents’ Resilience and Treatment for Mental health in Indian Slums (ARTEMIS). Prior to this she was working in Public Health Foundation of India (PHFI), New Delhi as a Senior Research Assistant.

Her interest areas are implementing public health projects at the grass root level, monitoring and evaluation, and capacity building trainings. She has good experience working in thematic areas like Non-communicable Diseases, Reproductive and Child Health.

Dr. Rajesh is a BHMS graduate and has completed a Post Graduate Program in Clinical Research & Clinical Data Management. He is currently working as a Clinical Research Associate at the George Institute. He is ICH GCP certified and carries over all 16 years of healthcare industry experience under different therapeutic areas, Clinical research, and phases of Clinical Trials. He has expertise in pharmacokinetic sampling and processing, centralized & remote monitoring, source data verification, CAPA, and regulatory reporting. 

Earlier, he worked as a duty medical officer & Health administrator, overseeing clinic operations at a corporate setup. His responsibilities have included clinical data management, patient management, protocol development, training, and regulatory compliance. His work demonstrates a commitment to holistic healthcare delivery and continuous professional development.

Rebecca has been at The George Institute Australia for 13 years, and was first part of the project operations team where she started as a clinical trials assistant on Kanyini Guidelines Adherence with the Polypill Study (Kanyini GAP) and then continued her career development within APO becoming a Clinical Research Associate and then a Senior Clinical Research Associate, during this time she has worked on many different projects within various programs at The Institute including renal and metabolic, neurological, critical care, cardiovascular and oncology programs.

Rebecca is now the Quality Assurance officer for Australia where she is now using her experience by supporting and assisting staff and researchers in the Australia office and the global Quality Assurance (QA) Team in their quality activities under the Quality Assurance Framework, Rebecca is also responsible for the coordination, reporting and training on research quality processes within Australia, and together with the Centre for Operational and Research Excellence (CORE) QA team providing training and advice of quality assurance, risk management, and QA training to the Australia office, including the coordination of Good Clinical Practice (GCP) training at The Institute.

Richard Lindley is Professor of Geriatric Medicine at Sydney Medical School (Westmead Hospital Clinical School), University of Sydney. His career has focused on finding reliable new evidence to improve treatments for older people, particularly stroke.

He continues in hospital clinical practice (acute geriatric medicine, rehabilitation and stroke at Blacktown Hospital, Sydney) and runs a large portfolio of clinical trials and projects within different groups at The George Institute.

He is an Associate Editor for the Australasian Journal on Ageing and an Honorary Overseas Member of the British Association of Neurologists. He has published widely on clinical aspects of stroke, vascular disease, vaccination, infectious disease and geriatric medicine.

Ritika Khan joined the Biostatistics department at The George Institute India as a Research Assistant in 2024. She completed her Master’s in Statistics from University of Calcutta. Prior to joining, Ritika had worked as an intern at The George Institute. She works across different projects and is responsible for providing statistical support related to study design, sample size calculation, analysis, and interpretation of findings. Ritika is interested in learning more about different therapeutic areas in clinical and public health and in the application of statistical techniques to problems in this field. 

Professor Rodney Phillips is Professor Emeritus at UNSW, Sydney and an Honorary Fellow of Oxford’s Pembroke College.

Rodney is an immunologist specialising in HIV and infectious diseases. He was Professor of Medicine and Head of Research and Associate Dean of Oxford University’s Division of Medical Sciences. He also served as Vice-Dean of Medical Sciences, Director of Peter Medawar Building for Pathogen Research and Co-Director of Oxford Martin Institute for Emerging Infections.

Rodney joined the Board in May 2017 and is a Member of the Risk Committee.

Ms. Rong LUO joined the George Institute for Global Health in January 2013 as research fellow. She is engaged in several research projects related to NCD, including stroke, mHealth systematic review and women health.

Ms. Rong LUO graduated from College of Public Health, Ningxia Medical University and got her master degree in 2007. From 2007 to 2012, she worked for the Office of Disease Control and Health Emergency Response and Office for China-US Collaboration Program on Emerging and Re-emerging Infectious Disease, Chinese Center for Disease Prevention and Control (China CDC). At China CDC, she worked as an project officer and participated in coordination for several major infectious disease epidemics control and health emergency (2008 Hand Foot Mouth Disease Epidemics Control/2008 Wenchuan Earthquake Health Emergency Response/2009 H1N1 Epidemics Control etc.), project management (including strategic plan and monitoring and evaluation), project implement (risk communication survey and study), capacity building and foreign affairs etc.

Professor Ruth Peters completed her PhD and NIHR Post-doctoral Fellowship at Imperial College London before relocating to Australia in 2018. Dr Peters' research combines clinical trials, evidence synthesis, and epidemiology to understand and treat risk factors for dementia and frailty. Her work has influenced WHO and national and international clinical practice guidelines, is used by health advocacy bodies and is regularly featured in the media, for example, Study finds evidence lowering blood pressure later in life can cut dementia risk

Prof Peters has been awarded >$10 million in research funding, is widely cited and is regularly invited to talk at conferences and scientific meetings. She has a particular passion for the two areas that show the most potential for helping healthy brain ageing, multidomain risk reduction and the treatment of Hypertension.

In multidomain risk reduction, Prof Peters is leading the first large multisite trial to test intergenerational practice, a novel multidomain intervention bringing older adults and preschool children together, combining physical activity, cognitive and social engagement to reduce cognitive decline and frailty and co-designed with community members.

In Hypertension, Dr Peters is currently leading an exciting new research stream at The George Institute for Global Health, including innovative clinical trial and evidence synthesis projects in blood pressure lowering, dementia and frailty and has an established international reputation since her early PhD work as cognitive function lead for the award-winning multinational Hypertension in the Very Elderly Trial (HYVET, HYVET -COG).

Associate Professor Ruth Webster is an Honorary Professorial Fellow at The George Institute. As a researcher, she has a particular interest in the development of novel strategies to bridge the evidence-practice gap in Cardiovascular Disease Prevention. She is actively involved in trials of various types of polypill strategies, as well as improving the use of technology in Australian general practice.